Holdings

Enavate Sciences Gp, LLC

As of Sep 30, 2026, Enavate Sciences Gp, LLC reported 8 positions worth US$280M. Largest: Zenas BioPharma, Inc., Immunome, Inc. and Braveheart Bio, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Zenas BioPharma, Inc.2.92MUS$78.7M−1MSep 30, 2026
Immunome, Inc.3.61MUS$77.7Mno changeSep 30, 2026
Braveheart Bio, Inc.3.67MUS$74.2MnewSep 30, 2026
Sionna Therapeutics, Inc.2.48MUS$13Mno changeSep 30, 2026
Upstream Bio, Inc.2.46MUS$13Mno changeSep 30, 2026
BridgeBio Oncology Therapeutics, Inc.2.63MUS$10.8Mno changeSep 30, 2026
Compass Therapeutics, Inc.7.79MUS$8.1Mno changeSep 30, 2026
CAMP4 Therapeutics Corporation1.04MUS$4.21M−384KSep 30, 2026